文献速递肝病消化道肿瘤与早癌

人CD96与自然杀伤细胞耗竭相关并预测肝细胞癌患者预后

Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
PubMed 文献 · Hepatology · 2019-03-05

研究检测55例新鲜肝细胞癌(HCC)样本、236例石蜡包埋HCC样本及20例正常肝脏中CD96、TIGIT和CD226的表达。结果显示肿瘤内CD96+自然杀伤(NK)细胞累积百分比、绝对计数和平均荧光强度显著升高,细胞功能耗竭;阻断CD96-CD155相互作用或TGF-β1可恢复NK细胞抗肿瘤免疫。肿瘤内CD96或CD155高表达与较差临床状态及更短无病生存期(DFS)和总生存期相关。

要点

  • 肿瘤内CD96+ NK细胞累积百分比、绝对计数和平均荧光强度显著升高,且细胞功能耗竭。
  • 阻断CD96-CD155相互作用可特异性增强NK细胞对HepG2细胞的裂解。
  • 肿瘤内CD96或CD155高表达与更差临床状态及更短DFS和总生存期强相关。

核心结论

  • 人肿瘤内CD96+ NK细胞功能耗竭,肿瘤内CD96表达较高的患者临床结局较差。
  • 阻断CD96-CD155相互作用或TGF-β1可通过逆转NK细胞耗竭恢复抗肿瘤免疫,提示CD96可能具有治疗肝癌的作用。

研究设计与样本

  • 研究检测55例新鲜人肝细胞癌样本、236例石蜡包埋肝细胞癌样本和20例正常人肝脏中CD96、TIGIT和CD226的表达。

主要发现

  • HCC肿瘤内CD96+ NK细胞的累积百分比、绝对计数和平均荧光强度显著增加,打破三种受体间的平衡。
  • 人CD96+ NK细胞功能耗竭,表现为干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNF-α)产生受损,白细胞介素(IL)-10和转化生长因子-β1(TGF-β1)基因高表达,T-bet、IL-15、穿孔素和颗粒酶B基因低表达。
  • 阻断CD96-CD155相互作用可特异性增加NK细胞对HepG2细胞的裂解。
  • 肿瘤内CD96或CD155高表达的HCC患者与恶化疾病状态及更短无病生存期(DFS)和总生存期强相关。
  • 肿瘤内CD96+ NK细胞累积百分比更高的患者DFS更短;HCC患者高血浆TGF-β1水平上调CD96表达并动态改变NK细胞中CD96、TIGIT和CD226间的平衡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint blockade has become a promising therapeutic approach to reverse immune cell exhaustion. Coinhibitory CD96 and T-cell immunoglobulin and ITIM domain (TIGIT), together with costimulatory CD226, bind to common ligand CD155. The balancing between three receptors fine-tunes immune responses against tumors. In this study, we investigated the expression of CD96, TIGIT, and CD226 in 55 fresh human hepatocellular carcinoma (HCC) samples, 236 paraffin-embedded HCC samples, and 20 normal human livers. The cumulative percentage, absolute count, and mean fluorescence intensity (MFI) of CD96+ NK cells are significantly increased in the intratumoral tissues of HCC and break the balance between three receptors. Human CD96+ NK cells are functionally exhausted with impaired interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) production, high gene expression of interleukin (IL)-10 and transforming growth factor-beta 1 (TGF-β1), and low gene expression of T-bet, IL-15, perforin, and granzyme B. In addition, blocking CD96-CD155 interaction specifically increases lysis of HepG2 cells by NK cells. HCC patients with a high level of CD96 or CD155 expression within tumor are strongly associated with deteriorating disease condition and shorter disease-free survival (DFS) and overall survival times. Patients with a higher cumulative percentage of CD96+ NK cells within tumor also exhibit shorter DFS. High plasma level of TGF-β1 in HCC patients up-regulates CD96 expression and dynamically shifts the balance between CD96, TIGIT, and CD226 in NK cells. Blocking TGF-β1 specifically restores normal CD96 expression and reverses the dysfunction of NK cells. Conclusion: These findings indicate that human intratumoral CD96+ NK cells are functionally exhausted and patients with higher intratumoral CD96 expression exhibit poorer clinical outcomes. Blocking CD96-CD155 interaction or TGF-β1 restores NK cell immunity against tumors by reversing NK cell exhaustion, suggesting a possible therapeutic role of CD96 in fighting liver cancer.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sun H, Huang Q, Huang M, et al. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30411378. doi:10.1002/hep.30347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。